Rhumbline Advisers Cardiovascular Systems Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$13.31 - $19.86 $93,103 - $138,920	6,995 Added 5.59%	132,048 $2.62 Million
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $98,480 - $116,877	7,730 Added 6.59%	125,053 $1.7 Million
Q3 2022 Nov 10, 2022	BUY	$12.93 - $17.17 $59,697 - $79,273	4,617 Added 4.1%	117,323 $1.63 Million
Q2 2022 Aug 11, 2022	BUY	$13.53 - $23.34 $97,023 - $167,371	7,171 Added 6.79%	112,706 $1.62 Million
Q1 2022 May 12, 2022	BUY	$16.14 - $22.6 $95,242 - $133,362	5,901 Added 5.92%	105,535 $2.39 Million
Q4 2021 Feb 10, 2022	BUY	$18.64 - $36.77 $10,550 - $20,811	566 Added 0.57%	99,634 $1.87 Million
Q3 2021 Nov 12, 2021	SELL	$32.83 - $43.0 $475,345 - $622,597	-14,479 Reduced 12.75%	99,068 $3.25 Million
Q2 2021 Aug 05, 2021	SELL	$34.41 - $44.03 $150,956 - $193,159	-4,387 Reduced 3.72%	113,547 $4.84 Million
Q1 2021 May 06, 2021	BUY	$37.29 - $47.19 $46,053 - $58,279	1,235 Added 1.06%	117,934 $4.52 Million
Q4 2020 Feb 10, 2021	BUY	$34.3 - $44.09 $264,315 - $339,757	7,706 Added 7.07%	116,699 $5.11 Million
Q3 2020 Nov 12, 2020	BUY	$27.86 - $39.35 $12,146 - $17,156	436 Added 0.4%	108,993 $4.29 Million
Q2 2020 Aug 13, 2020	SELL	$30.3 - $42.55 $156,954 - $220,408	-5,180 Reduced 4.55%	108,557 $3.43 Million
Q1 2020 May 06, 2020	BUY	$30.0 - $54.18 $79,200 - $143,035	2,640 Added 2.38%	113,737 $4.01 Million
Q4 2019 Feb 05, 2020	BUY	$42.29 - $52.2 $245,112 - $302,551	5,796 Added 5.5%	111,097 $5.4 Million
Q3 2019 Oct 23, 2019	BUY	$42.06 - $51.64 $130,596 - $160,342	3,105 Added 3.04%	105,301 $5 Million
Q2 2019 Aug 14, 2019	BUY	$33.93 - $43.66 $36,067 - $46,410	1,063 Added 1.05%	102,196 $4.39 Million
Q1 2019 May 01, 2019	BUY	$26.74 - $41.32 $1.53 Million - $2.36 Million	57,041 Added 129.37%	101,133 $3.91 Million
Q4 2018 Jan 31, 2019	BUY	$25.26 - $38.43 $361,495 - $549,971	14,311 Added 48.05%	44,092 $1.26 Million
Q3 2018 Nov 07, 2018	SELL	$33.27 - $39.25 $69,035 - $81,443	-2,075 Reduced 6.51%	29,781 $1.17 Million
Q2 2018 Aug 06, 2018	BUY	$21.73 - $33.15 $6,084 - $9,282	280 Added 0.89%	31,856 $1.03 Million
Q1 2018 May 02, 2018	SELL	$21.05 - $26.6 $1,052 - $1,330	-50 Reduced 0.16%	31,576 $692,000
Q4 2017 Feb 09, 2018	SELL	$23.37 - $29.26 $150,549 - $188,492	-6,442 Reduced 16.92%	31,626 $749,000
Q3 2017 Nov 06, 2017	BUY	$27.25 - $31.55 $1.04 Million - $1.2 Million	38,068	38,068 $1.07 Million

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account